1. Home
  2. BCDA vs LPTV Comparison

BCDA vs LPTV Comparison

Compare BCDA & LPTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCDA
  • LPTV
  • Stock Information
  • Founded
  • BCDA N/A
  • LPTV 2015
  • Country
  • BCDA United States
  • LPTV United States
  • Employees
  • BCDA N/A
  • LPTV N/A
  • Industry
  • BCDA Biotechnology: Pharmaceutical Preparations
  • LPTV Broadcasting
  • Sector
  • BCDA Health Care
  • LPTV Industrials
  • Exchange
  • BCDA Nasdaq
  • LPTV Nasdaq
  • Market Cap
  • BCDA 9.4M
  • LPTV 11.5M
  • IPO Year
  • BCDA N/A
  • LPTV N/A
  • Fundamental
  • Price
  • BCDA $2.83
  • LPTV $0.14
  • Analyst Decision
  • BCDA Strong Buy
  • LPTV Strong Buy
  • Analyst Count
  • BCDA 1
  • LPTV 2
  • Target Price
  • BCDA $60.00
  • LPTV $1.00
  • AVG Volume (30 Days)
  • BCDA 80.6K
  • LPTV 10.7M
  • Earning Date
  • BCDA 08-07-2024
  • LPTV 08-06-2024
  • Dividend Yield
  • BCDA N/A
  • LPTV N/A
  • EPS Growth
  • BCDA N/A
  • LPTV N/A
  • EPS
  • BCDA N/A
  • LPTV N/A
  • Revenue
  • BCDA $468,000.00
  • LPTV $25,596,950.00
  • Revenue This Year
  • BCDA N/A
  • LPTV N/A
  • Revenue Next Year
  • BCDA $436.41
  • LPTV $31.30
  • P/E Ratio
  • BCDA N/A
  • LPTV N/A
  • Revenue Growth
  • BCDA N/A
  • LPTV N/A
  • 52 Week Low
  • BCDA $2.62
  • LPTV $0.10
  • 52 Week High
  • BCDA $23.25
  • LPTV $2.55
  • Technical
  • Relative Strength Index (RSI)
  • BCDA 36.56
  • LPTV 44.50
  • Support Level
  • BCDA $2.85
  • LPTV $0.14
  • Resistance Level
  • BCDA $3.66
  • LPTV $0.17
  • Average True Range (ATR)
  • BCDA 0.29
  • LPTV 0.02
  • MACD
  • BCDA 0.04
  • LPTV 0.00
  • Stochastic Oscillator
  • BCDA 13.54
  • LPTV 50.18

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About LPTV Loop Media Inc.

Loop Media Inc is a multichannel digital video platform media company that uses marketing technology. The company is focused on premium short-form video. It offers music videos and film, game, and TV trailers which can be viewed in hospitality, dining, and retail venues, on branded media and entertainment sites, and on over-the-top TV platforms and IPTV devices.

Share on Social Networks: